PubMed · 12592880
Monitoring low molecular weight heparins.
Abstract
Low molecular weight heparin (LMWH) is used in the treatment of various thrombotic disorders. The clinical indications, pharmacology, and complications of therapy are reviewed. The indications for the need for monitoring include renal failure, obesity, pregnancy, and pediatric use. Monitoring focuses on the anti-Xa properties of LMWH. The two major assay types, chronometric (clotting) and chromogenic (amidolytic), are reviewed and compared.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Jack E Garon. Monitoring low molecular weight heparins.. https://pubmed.ncbi.nlm.nih.gov/12592880/
Cite the original work for its findings. Save a collection to share your selection of sources.